Marjan Mahdavi-Roshan

Marjan Mahdavi-Roshan

Auto-generated profile, based on publicly available information

Marjan Mahdavi-Roshan

Department of Clinical Nutrition, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Bone Abstracts
Verified
Journal Article
Closed access
MMMarjan Mahdavi-Roshan
Marjan Mahdavi-Roshan
MEMehrangiz Ebrahimi-Mameghani
Mehrangiz Ebrahimi-Mameghani
AEAliasgar Ebrahimi
Aliasgar Ebrahimi
Copper, magnesium, zinc and calcium status were measured in postmenopausal women with osteoporosis (n = 23) and osteopenia (n = 28) as classified on the basis of the T-score of the femur neck and dual energy X-ray absorptiometry results. Anthropometric indices, dietary intake and serum copper, magnesium, zinc and calcium were assessed. The results of our study showed that the mean dietary intake of magnesium, zinc and calcium in post-menopausal women with low bone density were significantly lower than recommended dietary allowance. The mean serum levels of zinc (P = 0.001) and copper (P = 0.000) were significantly lower than normal range and 40.4% of this participants had serum magnesium levels lower than normal range. No statistically significant differences were observed between the osteopenic and osteoporotic groups with respect to serum levels and dietary intakes of copper, calcium, magnesium and zinc. Due to the mineral deficiency in post-menopausal women with low bone density and the key role of minerals on bone health, supplementation with magnesium, calcium, zinc and perhaps copper recommended.

8 August 2022 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
ZGZeinab Ghorbani
Zeinab Ghorbani
AKAsma Kazemi
Asma Kazemi
TBTheda U.P. Bartolomaeus
Theda U.P. Bartolomaeus
FMFahimeh Martami
Fahimeh Martami
MNMorvarid Noormohammadi
Morvarid Noormohammadi
MMMarjan Mahdavi-Roshan
Marjan Mahdavi-Roshan
Although the available evidence emphasizes the beneficial effects of probiotics in normalizing various cardiometabolic markers, there is still substantial uncertainty in this regard. Thus, we set out to determine the effect sizes of probiotics on blood lipid parameters more coherently. A systematic literature search of the Medline (PubMed) and Scopus databases was conducted from inception to February 12, 2021, applying both MeSH terms and free text terms to find the relevant randomized controlled trials (RCTs). The meta-analysis was conducted based on a random-effect model to calculate the mean effect sizes demonstrated as weighted mean differences (WMD) and the 95% confidence intervals (95%CI). To explore the heterogeneity, the Cochrane Chi-squared test, and analysis of Galbraith plots were performed. Meta-analysis of data from 40 RCTs (n = 2795) indicated a significant decrease in serum/plasma triglyceride (WMD (95%CI) -12.26 (-17.11- -7.41) mg/dL; P-value <0.001; I2 (%)= 29.9; P heterogeneity = 0.034)), total cholesterol (with high heterogeneity) (WMD (95%CI) -8.43 (-11.90- -4.95) mg/dL; P-value <0.001; I2 (%) =56.8; P heterogeneity < 0.001), LDL-C (WMD (95%CI) -5.08 (-7.61, -2.56) mg/dL; P-value <0.001; I2 (%) =42.7; P heterogeneity =0.002), and HDL-C (with high heterogeneity) (WMD (95%CI) 1.14 (0.23, 2.05) mg/dL; P-value =0.014; I2 (%) = 59.8; P heterogeneity < 0.001) following receiving probiotic/synbiotic supplements. Collectively, the current preliminary evidence supports the effectiveness of probiotics/synbiotics in improving dyslipidemia and various lipid parameters more prominently among subjects with hyperlipidemia, diabetes, and metabolic syndrome. However, large and well conducted RCTs are required to provide further convincing support for these results.

1 April 2013 in Nutrition and Health
Verified
Journal Article
Closed access
PDF file
MMMarjan Mahdavi-Roshan
Marjan Mahdavi-Roshan
AZAli Zahedmehr
Ali Zahedmehr
AMAli Mohammad-Zadeh
Ali Mohammad-Zadeh
HSHamid-Reza Sanati
Hamid-Reza Sanati
FSFarshad Shakerian
Farshad Shakerian
JNJavad Nasrollahzadeh
Javad Nasrollahzadeh
Background/objectives: This study was designed to investigate whether garlic powder tablets in adjunct to conventional medical treatment could have an effect on carotid intima-media thickness (CIMT) and plasma lipoproteins and lipids in patients with coronary artery disease (CAD). Subjects/methods: A randomized, placebo-controlled, clinical trial was conducted on 56 patients with CAD between the ages of 25 and 75 years. The patients were randomly divided into two groups: garlic group ( n = 27), receiving garlic powder tablet (1200 µg allicin/tab) twice daily and the placebo group ( n = 29), receiving placebo for 3 months. The rate of atherosclerosis progression was measured by B-mode ultrasonography as the increase in CIMT. Results: After 3 months of taking garlic tablets, CIMT values had minor variations (0.009 ± 0.007 mm reduction from baseline), while in the placebo group, an increase in CIMT values was observed (0.04 ± 0.01 mm increase from baseline). After 3 months of treatment, mean CIMT difference from baseline was significantly differ between the two groups ( p < 0.001). Plasma lipids and lipoproteins (total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, Apolipoprotein A1 and Apolipoprotein B) did not differ between the two groups. Conclusions: The results suggest that dry garlic powder tablet is superior to placebo in prevention of CIMT progression in patients with CAD and may be considered as an adjunct treatment for atherosclerosis.

24 August 2016 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
MMMarjan Mahdavi-Roshan
Marjan Mahdavi-Roshan
JNJavad Nasrollahzadeh
Javad Nasrollahzadeh
AZAli Mohammad Zadeh
Ali Mohammad Zadeh
AZAli Zahedmehr
Ali Zahedmehr
Background: Hypertension is one of the major risk factors for cardiovascular morbidities, including coronary artery disease (CAD). Objectives: With interest on the important role of hypertension in the progression of CAD, this study was designed to estimate the effect of garlic powder tablets on the blood pressure (BP) in patients with severe CAD. Methods: A randomized, placebo-controlled, clinical trial was conducted on 56 CAD patients, aged 25 - 75 years old. The patients were randomly divided into two groups: Galois groups (n = 27), receiving garlic powder tablet (400 mg garlic) twice daily and the placebo groups (n = 29), receiving placebo for 3 months. The BP was assessed at baseline and at the end of the study. Results: During the 3 months study, in the placebo group, systolic BP (SBP) increased with 6.3 mmHg and diastolic BP (DBP) increased with 4.6 mmHg, changes which were significant. After the 3 months, the effect of garlic on SBP, after adjusting for baseline value, was significant, and this effect was more significant in hypertensive patients. Plasma lipids and lipoproteins did not change significantly in either the garlic or placebo groups, during the study. Tolerability, compliance and acceptability were high in all patients. Conclusions: These results demonstrate that treatment with garlic-based drugs can be an effective treatment for controlling BP in CAD patients and has no interaction with other drugs that CAD patients take. Therefore, it may be considered as a safe adjunct treatment for this group of patients. Keywords: Hypertension; Coronary Artery Disease; Garlic; Systolic Pressure; Diastolic Pressure

1 December 2016 in Medicine
Verified
Journal Article
Open access
ASArsalan Salari
Arsalan Salari
MSMaryam Shakiba
Maryam Shakiba
MMMarjan Mahdavi-Roshan
Marjan Mahdavi-Roshan
MGMahboobeh Gholipour
Mahboobeh Gholipour
MNMoona Naghshbandi
Moona Naghshbandi
RRRamin Rajabi
Ramin Rajabi
Recent observational studies have reported controversial results for the association between different anthropometric indices of obesity and severity of atherosclerosis. The aim of the current study is to determine the associations between anthropometric indices with severity of atherosclerosis in adult population in north of Iran. The cross-sectional study was performed on 610 participants, who were admitted to a hospital for elective angiographyin Rasht, Iran, Anthropometric indices, including waist circumference (WC), waist-to-height ratio (WHtR), conicity index (CI), body mass index (BMI), and hematological factors, were measured using the standard methods. According to angiography reports, severity of atherosclerosis was determined. Sixty-two percent of participants had moderate to severe atherosclerosis. According to BMI, 44% were overweight and 25.8% were obese. Based on WHtR and WC, 90%, and 57% were obese, respectively. The prevalence of moderate to severe atherosclerosis in centrally obese women was significantly higher than in centrally nonobese women (52% vs 28% P = 0.02). According to multivariate adjustment analysis, age, sex, systolic blood pressure, hemoglobin A1c, uric acid, and triglyceride were independently associated with severity of atherosclerosis. BMI, WC, CI, and WHtR had no significant association with severity of atherosclerosis. Our findings showed that anthropometric indices reflective of general and abdominal obesity were not independently related to the severity of atherosclerosis in adults, in northern Iran.

1 September 2008 in Saudi Medical Journal
Verified
Journal Article
Closed access
ASAli Sadighi
Ali Sadighi
MRMarjan M. Roshan
Marjan M. Roshan
AMAmin Moradi
Amin Moradi
AOAlireza Ostadrahimi
Alireza Ostadrahimi
OBJECTIVES To determine the effect of zinc supplementation on callus formation, serum zinc and alkaline phosphatase activity in humans. METHODS This randomized, double-blind, placebo controlled clinical trial was conducted on 60 patients with traumatic bone fracture referred to Shohada Hospital of Tabriz, Iran from August to December 2007. Subjects were randomly divided into 2 groups: cases (n=30), receiving one capsule of zinc sulfate consists of 50 mg zinc each day and the controls (n=30), receiving placebo for 60 days. Individual and clinical information was determined by a questionnaire: nutritional intake by 3 days food records at the beginning and the end of trial. Serum zinc and alkaline phosphatase was measured by atomic absorption spectroscopy, and by enzymatic method. Callus formation during fracture healing was evaluated by radiography of the bone. RESULTS There was no significant difference in physical activity, gender, age, type of fractures, and nutrient intake, between the 2 groups. The administration of zinc caused a significant elevation of serum zinc and alkaline phosphatase activity. Assessment of bone x- rays showed a significant progress in callus formation in cases compared to the controls. CONCLUSIONS This study shows that zinc supplementation can stimulate fracture healing, however, it needs further study.